AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201600020CGEOVAX, INC.
Overview
Award facts
- Net obligations
- $197.76K
- $197,761of $7.83M potential value
- Period of performance
- Nov 14, 2018 to Dec 31, 2017
- Ended
- Modifications
- 2
- Latest action Nov 14, 2018
- Contract type
- Definitive contract
- PIID HHSN272201600020C
Description of requirement
IGF::OT::IGF STAGE VACCINE DEVELOPMENT
Dates and value
- Award date
- Signed on Aug 1, 2016
- Potential end of performance
- Apr 29, 2022
- Current value
- $197,761Base and exercised options
- Potential value (if all options are exercised)
- $7,833,416
Obligations by fiscal year of action
- FY2019: -$1,681 (de-obligation)
- FY2016: $199,442
Total across 2 fiscal years: $197,761
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 14, 2018. View on USAspending · Recipient on SAM.gov
Recipient
NameGEOVAX, INC.
LocationSMYRNA, GA
UEICEF5ULT44LF5
CAGE code4DG62
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyGEOVAX, INC.
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Smyrna, Cobb County, Georgia 30080-7648
- Congressional district (place of performance)
- GA-06As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN81R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- NIHAI2015040(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Stage vaccine development
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 1, 2016Base obligation at award: $199,442
- Latest action
- Nov 14, 2018 — CloseoutModification P00002; obligation change -$1,681; administrative: no change in scope or value
- Actions by type
- Base award1
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$1,681
- Latest action: change in base and all options
- -$1,681
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2016/2016-0885-000
- Object classes
- 25.5: Research and development contracts